Detalhe da pesquisa
1.
Discovery of an orally bioavailable isoxazoline benzoxaborole (AN8030) as a long acting animal ectoparasiticide.
Bioorg Med Chem Lett
; 25(23): 5589-93, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508546
2.
Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties.
Bioorg Med Chem Lett
; 21(7): 2048-54, 2011 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21353550
3.
Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease.
Bioorg Med Chem Lett
; 20(24): 7493-7, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21041080
4.
Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease.
Bioorg Med Chem Lett
; 20(24): 7317-22, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21067923
5.
Novel macrocyclic HCV NS3 protease inhibitors derived from α-amino cyclic boronates.
Bioorg Med Chem Lett
; 20(19): 5695-700, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20801653
6.
Synthesis and evaluation of novel alpha-amino cyclic boronates as inhibitors of HCV NS3 protease.
Bioorg Med Chem Lett
; 20(12): 3550-6, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20493689
7.
Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656).
J Med Chem
; 60(19): 8011-8026, 2017 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28953378